Pharma company Jubilant Life Sciences is planning to invest Rs 300 crore in research and development (R&D) in FY19.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Mriivm
via IFTTT
Jubilant Life Sciences plans Rs 550-cr capex in FY19
Pharma company Jubilant Life Sciences is planning to invest Rs 300 crore in research and development (R&D) in FY19.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Mriivm
via IFTTT
0 comments:
Post a Comment